These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25923942)

  • 21. Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis.
    Romero Gómez M; Suárez García E; López Lacomba D; Marchante I; Grande L; Castro Fernandez M
    J Clin Gastroenterol; 2000 Oct; 31(3):237-40. PubMed ID: 11034005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
    Amitrano L; Guardascione MA; Brancaccio V; Margaglione M; Manguso F; Iannaccone L; Grandone E; Balzano A
    J Hepatol; 2004 May; 40(5):736-41. PubMed ID: 15094219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis.
    La Mura V; Tripodi A; Tosetti G; Cavallaro F; Chantarangkul V; Colombo M; Primignani M
    Liver Int; 2016 Sep; 36(9):1322-30. PubMed ID: 26854258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.
    Chaireti R; Rajani R; Bergquist A; Melin T; Friis-Liby IL; Kapraali M; Kechagias S; Lindahl TL; Almer S
    Thromb Res; 2014 Aug; 134(2):455-61. PubMed ID: 24913997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased plasma prothrombin concentration in cirrhotic patients with portal vein thrombosis and prothrombin G20210A mutation.
    Amitrano L; Guardascione MA; Ames PR; Margaglione M; Iannaccone L; Brancaccio V; Balzano A
    Thromb Haemost; 2006 Feb; 95(2):221-3. PubMed ID: 16493481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system.
    Abdel-Razik A; Mousa N; Elhelaly R; Tawfik A
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):585-92. PubMed ID: 25769098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital Thrombophilia in Patients With Superior Mesenteric Venous Thrombosis or Portal Vein Thrombosis.
    Makoto I; Usui M; Wada H; Matsumoto T; Ohishi K; Shindo A; Yamashita Y; Nakatani K; Tamaki S; Tomimoto H; Isaji S
    Clin Appl Thromb Hemost; 2018 Oct; 24(7):1117-1121. PubMed ID: 29747524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis.
    Lebreton A; Sinegre T; Pereira B; Lamblin G; Duron C; Abergel A
    J Gastroenterol Hepatol; 2017 Apr; 32(4):916-924. PubMed ID: 27421039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study.
    Gao B; Xiao J; Zhang M; Zhang F; Zhang W; Yang J; He J; Liu Y; Zou X; Xu P; Zhuge Y
    Lipids Health Dis; 2019 Mar; 18(1):79. PubMed ID: 30927926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
    Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
    BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients.
    Ayala R; Martínez-López J; Cedena T; Bustelos R; Jimenez C; Moreno E; Ribera C
    BMC Gastroenterol; 2011 Nov; 11():130. PubMed ID: 22123067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study.
    Lancellotti S; Basso M; Veca V; Sacco M; Riccardi L; Pompili M; De Cristofaro R
    Intern Emerg Med; 2016 Oct; 11(7):959-67. PubMed ID: 27220954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis.
    Raffa S; Reverter JC; Seijo S; Tassies D; Abraldes JG; Bosch J; García-Pagán JC
    Clin Gastroenterol Hepatol; 2012 Jan; 10(1):72-8. PubMed ID: 21946303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis.
    Fimognari FL; De Santis A; Piccheri C; Moscatelli R; Gigliotti F; Vestri A; Attili A; Violi F
    J Lab Clin Med; 2005 Oct; 146(4):238-43. PubMed ID: 16194685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypercoagulability in end-stage liver disease: prevalence and its correlation with severity of liver disease and portal vein thrombosis.
    Singhal A; Karachristos A; Bromberg M; Daly E; Maloo M; Jain AK
    Clin Appl Thromb Hemost; 2012 Nov; 18(6):594-8. PubMed ID: 22496089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel insights into the development of portal vein thrombosis in cirrhosis patients.
    Qi X; Li H; Liu X; Yao H; Han G; Hu F; Shao L; Guo X
    Expert Rev Gastroenterol Hepatol; 2015; 9(11):1421-32. PubMed ID: 26325361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis.
    Chen H; Liu L; Qi X; He C; Wu F; Fan D; Han G
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):82-9. PubMed ID: 26513611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High FVIII level is associated with idiopathic portal vein thrombosis in South India.
    Koshy A; Jeyakumari M
    Am J Med; 2007 Jun; 120(6):552.e9-11. PubMed ID: 17524760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct-acting antivirals.
    Russo FP; Zanetto A; Campello E; Bulato C; Shalaby S; Spiezia L; Gavasso S; Franceschet E; Radu C; Senzolo M; Burra P; Lisman T; Simioni P
    Liver Int; 2018 Dec; 38(12):2210-2218. PubMed ID: 29738632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in levels of blood coagulation inhibitors in cirrhosis. Prospective study in 33 patients].
    Dumontier I; Alhenc-Gelas M; Chatellier G; Brenet P; Aiach M; Petite JP
    Gastroenterol Clin Biol; 1992; 16(2):120-5. PubMed ID: 1314744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.